PFA pursuant to regulation 33 of Listing Regulations, herewith Audited Financial Results (Standalone & Consolidated) for the Quarter ended 31.03.2026 along with statement of Assets & Liabilities ....
Awaiting price reaction for this filing.
Uniworth International Ltd reported audited financial results for FY2026 with a qualified opinion from auditor Khandelwal Ray & Co on both standalone and consolidated basis. The company posted a net loss of Rs. 157.01 Lacs before tax for standalone (Rs. 156.91 Lacs consolidated), with negative net worth of Rs. 12,025.13 Lacs. Total Assets stood at Rs. 3,342.10 Lacs against Total Liabilities of Rs. 1,536.73 Lacs (standalone). Multiple audit qualifications were raised due to non-provision of doubtful debts including Rs. 3,010.57 Lacs in overdue export receivables, Rs. 227.73 Lacs in settlement claims, Rs. 53.39 Lacs in miscellaneous advances, and Rs. 5.12 Lacs in sick company investment. For consolidated results, auditors were denied access to subsidiary Uniworth Biotech Limited's financials. The company's business operations remain suspended since long.
The qualified audit opinion with multiple repetitive qualifications and negative net worth signals significant financial distress. Investors should be cautious as the company has not made provisions for substantial doubtful receivables totaling over Rs. 3,300 Lacs, and auditors cannot verify subsidiary financials. The stock carries high risk given ongoing losses and weak balance sheet.